HK Stock MarketDetailed Quotes

02607 SH PHARMA

Watchlist
  • 13.020
  • +0.020+0.15%
Market Closed Dec 2 16:08 CST
48.24BMarket Cap10.80P/E (TTM)

SH PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Cash flow from operating activities
Earning before tax
----
5.28%3.6B
----
-26.11%5.17B
----
-25.14%3.42B
----
11.43%6.99B
----
9.59%4.56B
Profit adjustment
Investment loss (gain)
----
-622.31%-342.02M
----
73.90%-176M
----
117.54%65.48M
----
66.24%-674.26M
----
78.97%-373.27M
Impairment and provisions:
----
22.04%329.78M
----
30.64%841.24M
----
51.60%270.22M
----
360.73%643.93M
----
-3.90%178.24M
-Other impairments and provisions
----
-12.80%293.26M
----
-10.40%279.96M
----
54.49%336.32M
----
46,192.99%312.46M
----
8.25%217.69M
Revaluation surplus:
----
41.94%-114.29M
----
-85.03%-404.73M
----
-675.23%-196.84M
----
-206.18%-218.74M
----
-171.34%-25.39M
Asset sale loss (gain):
----
-88.91%-139.31M
----
93.57%-92.48M
----
94.83%-73.75M
----
-2,368.58%-1.44B
----
-23,988.34%-1.43B
-Loss (gain) on sale of property, machinery and equipment
----
-88.91%-139.31M
----
93.57%-92.48M
----
94.83%-73.75M
----
-2,368.58%-1.44B
----
-23,988.34%-1.43B
Depreciation and amortization:
----
5.97%1.25B
----
-1.36%2.38B
----
-0.99%1.18B
----
3.88%2.41B
----
1.44%1.19B
-Amortization of intangible assets
----
5.22%198.8M
----
-2.14%380.6M
----
-5.75%188.94M
----
-8.69%388.91M
----
-2.18%200.45M
-Other depreciation and amortization
----
-13.56%85.95M
----
-1.46%192.33M
----
16.79%99.43M
----
4.44%195.19M
----
-4.81%85.14M
Financial expense
----
-4.95%915.72M
----
9.47%1.86B
----
14.92%963.41M
----
8.49%1.7B
----
17.71%838.33M
Change of operating capital
Inventory (increase) decrease
----
-8.38%1.34B
----
67.61%-2.3B
----
344.06%1.46B
----
-122.17%-7.11B
----
-227.79%-597.24M
Accounts receivable (increase)decrease
----
25.37%-7.87B
----
36.20%-6.43B
----
-30.21%-10.54B
----
-63.78%-10.08B
----
-20.30%-8.1B
Accounts payable increase (decrease)
----
-68.98%1.62B
----
-63.74%4.59B
----
70.05%5.23B
----
118.29%12.65B
----
-19.00%3.08B
Special items of business
----
46.66%-68.55M
----
-55.73%-190.9M
----
-207.76%-128.52M
----
-170.75%-122.59M
----
-19.26%119.26M
Adjustment items of business operations
20.87%2.78B
-66.96%583.86M
-108.65%-5.47B
11.44%5.42B
1,550.33%2.3B
361.60%1.77B
-5.35%-2.62B
-0.45%4.87B
-105.43%-158.75M
-133.38%-675.44M
Net cash from operations
20.87%2.78B
-68.55%515.3M
-108.65%-5.47B
10.29%5.23B
1,550.33%2.3B
394.58%1.64B
-5.35%-2.62B
-6.28%4.74B
-105.43%-158.75M
-125.62%-556.18M
Cash flow from investment activities
Dividend received - investment
36.03%971.32M
122.44%701.77M
4.18%120.9M
11.68%982.75M
23.04%714.04M
20.77%315.48M
38,581.96%116.05M
16.96%879.94M
14.62%580.31M
-13.61%261.21M
Sale of fixed assets
8.20%159.08M
46.92%138.69M
-95.96%815.73K
11.73%179.15M
34.59%147.03M
-9.00%94.4M
-67.91%20.22M
-16.01%160.34M
50.90%109.24M
95.21%103.74M
Purchase of fixed assets
19.67%-1.84B
7.35%-1.39B
-25.93%-871.62M
-10.64%-2.97B
-16.91%-2.28B
-46.70%-1.5B
-19.43%-692.12M
34.81%-2.68B
-9.67%-1.95B
10.89%-1.03B
Sale of subsidiaries
--12.36M
----
105.03%11.51M
-99.53%500K
----
----
--5.62M
-6.07%106.8M
--3.54M
----
Acquisition of subsidiaries
40.23%-93.69M
44.69%-83.51M
96.94%-4.03M
-323.42%-357.08M
38.99%-156.75M
20.64%-150.98M
22.31%-132.08M
92.69%-84.33M
74.56%-256.95M
77.69%-190.26M
Recovery of cash from investments
-25.97%17.45B
-9.52%11.35B
8.92%10.05B
-8.54%26.88B
10.25%23.58B
15.83%12.54B
--9.23B
1,058.86%29.39B
1,021.22%21.39B
1,100.77%10.83B
Cash on investment
37.51%-15.86B
41.37%-8.4B
33.81%-7.1B
31.01%-27.38B
25.11%-25.38B
33.01%-14.33B
---10.73B
-1,160.67%-39.68B
-1,231.26%-33.89B
-1,852.30%-21.39B
Other items in the investment business
-219.59%-452.97M
-167.90%-280.57M
-580.74%-365.84M
130.92%171.42M
670.90%378.77M
4,650.56%413.22M
38.07%76.1M
53.37%-554.36M
95.44%-66.35M
99.33%-9.08M
Net cash from investment operations
111.93%357.98M
177.76%2.03B
187.44%1.84B
80.02%-2.49B
78.70%-3B
77.10%-2.61B
-233.74%-2.11B
-107.35%-12.47B
-227.02%-14.08B
-257.63%-11.42B
Net cash before financing
550.58%3.14B
361.05%2.55B
23.21%-3.63B
135.44%2.74B
95.11%-697.09M
91.85%-976.23M
-51.53%-4.73B
-710.04%-7.73B
-930.42%-14.24B
-1,072.13%-11.97B
Cash flow from financing activities
New borrowing
-2.80%45.51B
5.04%35.6B
-8.90%18.44B
31.95%64.2B
29.44%46.82B
30.14%33.9B
39.89%20.24B
29.55%48.65B
12.65%36.17B
146.99%26.05B
Refund
-0.08%-50.54B
6.68%-35.83B
14.68%-17.41B
-20.95%-72.34B
-16.20%-50.5B
-26.19%-38.39B
-32.18%-20.41B
-14.54%-59.81B
0.69%-43.46B
-63.21%-30.42B
Issuance of bonds
-25.00%9B
-50.00%6B
-50.00%3B
0.03%15B
-20.00%12B
33.32%12B
0.04%6B
-21.06%14.99B
-6.23%15B
-9.98%9B
Dividends paid - financing
21.23%-3.43B
20.87%-1.1B
32.40%-657.03M
-30.44%-4.92B
-38.72%-4.36B
-40.33%-1.39B
-97.72%-971.89M
-13.41%-3.77B
-8.23%-3.14B
-15.99%-993.22M
Absorb investment income
-94.84%18.32M
-98.81%3.74M
----
-97.49%354.28M
-97.46%355.19M
-97.75%314.36M
-98.88%156.81M
8,239.98%14.12B
13,400.69%14B
25,097.43%14B
Other items of the financing business
72.44%-420.16M
29.36%-911.59M
83.70%-113.39M
-0.48%-2.06B
-7.45%-1.52B
1.38%-1.29B
22.17%-695.79M
-629.79%-2.05B
-290.64%-1.42B
-288.42%-1.31B
Net cash from financing operations
-95.11%136.78M
-26.67%3.76B
-24.64%3.25B
-98.09%231.85M
-83.70%2.8B
-68.55%5.13B
-75.49%4.31B
675.32%12.14B
648.59%17.16B
808.77%16.32B
Effect of rate
62.41%-22.87M
-762.80%-8.19M
161.07%7.74M
55.14%-5.58M
-374.02%-60.84M
4.02%-948.93K
-1,914.09%-12.67M
75.28%-12.44M
123.86%22.2M
10.28%-988.68K
Net Cash
56.17%3.28B
51.89%6.31B
8.37%-381.61M
-32.60%2.97B
-27.94%2.1B
-4.34%4.16B
-102.88%-416.49M
621.13%4.41B
220.26%2.91B
461.21%4.34B
Begining period cash
12.09%27.5B
12.09%27.5B
12.09%27.5B
21.83%24.53B
21.83%24.53B
21.83%24.53B
21.83%24.53B
2.87%20.14B
2.87%20.14B
2.87%20.14B
Cash at the end
15.74%30.75B
17.83%33.8B
12.53%27.13B
12.09%27.5B
15.17%26.57B
17.19%28.69B
-30.36%24.1B
21.83%24.53B
13.14%23.07B
20.30%24.48B
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
--
PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Cash flow from operating activities
Earning before tax ----5.28%3.6B-----26.11%5.17B-----25.14%3.42B----11.43%6.99B----9.59%4.56B
Profit adjustment
Investment loss (gain) -----622.31%-342.02M----73.90%-176M----117.54%65.48M----66.24%-674.26M----78.97%-373.27M
Impairment and provisions: ----22.04%329.78M----30.64%841.24M----51.60%270.22M----360.73%643.93M-----3.90%178.24M
-Other impairments and provisions -----12.80%293.26M-----10.40%279.96M----54.49%336.32M----46,192.99%312.46M----8.25%217.69M
Revaluation surplus: ----41.94%-114.29M-----85.03%-404.73M-----675.23%-196.84M-----206.18%-218.74M-----171.34%-25.39M
Asset sale loss (gain): -----88.91%-139.31M----93.57%-92.48M----94.83%-73.75M-----2,368.58%-1.44B-----23,988.34%-1.43B
-Loss (gain) on sale of property, machinery and equipment -----88.91%-139.31M----93.57%-92.48M----94.83%-73.75M-----2,368.58%-1.44B-----23,988.34%-1.43B
Depreciation and amortization: ----5.97%1.25B-----1.36%2.38B-----0.99%1.18B----3.88%2.41B----1.44%1.19B
-Amortization of intangible assets ----5.22%198.8M-----2.14%380.6M-----5.75%188.94M-----8.69%388.91M-----2.18%200.45M
-Other depreciation and amortization -----13.56%85.95M-----1.46%192.33M----16.79%99.43M----4.44%195.19M-----4.81%85.14M
Financial expense -----4.95%915.72M----9.47%1.86B----14.92%963.41M----8.49%1.7B----17.71%838.33M
Change of operating capital
Inventory (increase) decrease -----8.38%1.34B----67.61%-2.3B----344.06%1.46B-----122.17%-7.11B-----227.79%-597.24M
Accounts receivable (increase)decrease ----25.37%-7.87B----36.20%-6.43B-----30.21%-10.54B-----63.78%-10.08B-----20.30%-8.1B
Accounts payable increase (decrease) -----68.98%1.62B-----63.74%4.59B----70.05%5.23B----118.29%12.65B-----19.00%3.08B
Special items of business ----46.66%-68.55M-----55.73%-190.9M-----207.76%-128.52M-----170.75%-122.59M-----19.26%119.26M
Adjustment items of business operations 20.87%2.78B-66.96%583.86M-108.65%-5.47B11.44%5.42B1,550.33%2.3B361.60%1.77B-5.35%-2.62B-0.45%4.87B-105.43%-158.75M-133.38%-675.44M
Net cash from operations 20.87%2.78B-68.55%515.3M-108.65%-5.47B10.29%5.23B1,550.33%2.3B394.58%1.64B-5.35%-2.62B-6.28%4.74B-105.43%-158.75M-125.62%-556.18M
Cash flow from investment activities
Dividend received - investment 36.03%971.32M122.44%701.77M4.18%120.9M11.68%982.75M23.04%714.04M20.77%315.48M38,581.96%116.05M16.96%879.94M14.62%580.31M-13.61%261.21M
Sale of fixed assets 8.20%159.08M46.92%138.69M-95.96%815.73K11.73%179.15M34.59%147.03M-9.00%94.4M-67.91%20.22M-16.01%160.34M50.90%109.24M95.21%103.74M
Purchase of fixed assets 19.67%-1.84B7.35%-1.39B-25.93%-871.62M-10.64%-2.97B-16.91%-2.28B-46.70%-1.5B-19.43%-692.12M34.81%-2.68B-9.67%-1.95B10.89%-1.03B
Sale of subsidiaries --12.36M----105.03%11.51M-99.53%500K----------5.62M-6.07%106.8M--3.54M----
Acquisition of subsidiaries 40.23%-93.69M44.69%-83.51M96.94%-4.03M-323.42%-357.08M38.99%-156.75M20.64%-150.98M22.31%-132.08M92.69%-84.33M74.56%-256.95M77.69%-190.26M
Recovery of cash from investments -25.97%17.45B-9.52%11.35B8.92%10.05B-8.54%26.88B10.25%23.58B15.83%12.54B--9.23B1,058.86%29.39B1,021.22%21.39B1,100.77%10.83B
Cash on investment 37.51%-15.86B41.37%-8.4B33.81%-7.1B31.01%-27.38B25.11%-25.38B33.01%-14.33B---10.73B-1,160.67%-39.68B-1,231.26%-33.89B-1,852.30%-21.39B
Other items in the investment business -219.59%-452.97M-167.90%-280.57M-580.74%-365.84M130.92%171.42M670.90%378.77M4,650.56%413.22M38.07%76.1M53.37%-554.36M95.44%-66.35M99.33%-9.08M
Net cash from investment operations 111.93%357.98M177.76%2.03B187.44%1.84B80.02%-2.49B78.70%-3B77.10%-2.61B-233.74%-2.11B-107.35%-12.47B-227.02%-14.08B-257.63%-11.42B
Net cash before financing 550.58%3.14B361.05%2.55B23.21%-3.63B135.44%2.74B95.11%-697.09M91.85%-976.23M-51.53%-4.73B-710.04%-7.73B-930.42%-14.24B-1,072.13%-11.97B
Cash flow from financing activities
New borrowing -2.80%45.51B5.04%35.6B-8.90%18.44B31.95%64.2B29.44%46.82B30.14%33.9B39.89%20.24B29.55%48.65B12.65%36.17B146.99%26.05B
Refund -0.08%-50.54B6.68%-35.83B14.68%-17.41B-20.95%-72.34B-16.20%-50.5B-26.19%-38.39B-32.18%-20.41B-14.54%-59.81B0.69%-43.46B-63.21%-30.42B
Issuance of bonds -25.00%9B-50.00%6B-50.00%3B0.03%15B-20.00%12B33.32%12B0.04%6B-21.06%14.99B-6.23%15B-9.98%9B
Dividends paid - financing 21.23%-3.43B20.87%-1.1B32.40%-657.03M-30.44%-4.92B-38.72%-4.36B-40.33%-1.39B-97.72%-971.89M-13.41%-3.77B-8.23%-3.14B-15.99%-993.22M
Absorb investment income -94.84%18.32M-98.81%3.74M-----97.49%354.28M-97.46%355.19M-97.75%314.36M-98.88%156.81M8,239.98%14.12B13,400.69%14B25,097.43%14B
Other items of the financing business 72.44%-420.16M29.36%-911.59M83.70%-113.39M-0.48%-2.06B-7.45%-1.52B1.38%-1.29B22.17%-695.79M-629.79%-2.05B-290.64%-1.42B-288.42%-1.31B
Net cash from financing operations -95.11%136.78M-26.67%3.76B-24.64%3.25B-98.09%231.85M-83.70%2.8B-68.55%5.13B-75.49%4.31B675.32%12.14B648.59%17.16B808.77%16.32B
Effect of rate 62.41%-22.87M-762.80%-8.19M161.07%7.74M55.14%-5.58M-374.02%-60.84M4.02%-948.93K-1,914.09%-12.67M75.28%-12.44M123.86%22.2M10.28%-988.68K
Net Cash 56.17%3.28B51.89%6.31B8.37%-381.61M-32.60%2.97B-27.94%2.1B-4.34%4.16B-102.88%-416.49M621.13%4.41B220.26%2.91B461.21%4.34B
Begining period cash 12.09%27.5B12.09%27.5B12.09%27.5B21.83%24.53B21.83%24.53B21.83%24.53B21.83%24.53B2.87%20.14B2.87%20.14B2.87%20.14B
Cash at the end 15.74%30.75B17.83%33.8B12.53%27.13B12.09%27.5B15.17%26.57B17.19%28.69B-30.36%24.1B21.83%24.53B13.14%23.07B20.30%24.48B
Cash balance analysis
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)------PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data